BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33475723)

  • 21. Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases.
    Germano IM; Carai A; Pawha P; Blacksburg S; Lo YC; Green S
    Clin Exp Metastasis; 2016 Feb; 33(2):143-9. PubMed ID: 26578533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
    Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Volumetric Dosimetry Analysis of Vertebral Body Fracture Risk After Single Fraction Spine Stereotactic Body Radiation Therapy.
    Lee MY; Ouyang Z; LaHurd D; Xia P; Chao ST; Suh JH; Angelov L; Magnelli A; Balik S; Balagamwala EH
    Pract Radiat Oncol; 2021; 11(6):480-487. PubMed ID: 34303836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
    Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.
    Zeng KL; Sahgal A; Husain ZA; Myrehaug S; Tseng CL; Detsky J; Sarfehnia A; Ruschin M; Campbell M; Foster M; Das S; Lipsman N; Bjarnason GA; Atenafu EG; Maralani PJ; Soliman H
    J Neurooncol; 2021 Mar; 152(1):173-182. PubMed ID: 33453002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.
    Guckenberger M; Mantel F; Gerszten PC; Flickinger JC; Sahgal A; Létourneau D; Grills IS; Jawad M; Fahim DK; Shin JH; Winey B; Sheehan J; Kersh R
    Radiat Oncol; 2014 Oct; 9():226. PubMed ID: 25319530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials.
    Tao R; Bishop AJ; Brownlee Z; Allen PK; Settle SH; Chang EL; Wang X; Amini B; Tannir NM; Tatsui C; Rhines LD; Brown PD; Ghia AJ
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1405-1413. PubMed ID: 27209509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of spinal SBRT. Is it important to select the treatment time?
    Pérez-Montero H; Godino O; Lozano A; Asiáin L; Martínez I; Sánchez JJ; de BlasFernández R; Fernández E; Stefanovic M; García N; Martínez J; Guedea F; Navarro-Martin A
    Clin Transl Oncol; 2022 Feb; 24(2):276-287. PubMed ID: 34342817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volume of Lytic Vertebral Body Metastatic Disease Quantified Using Computed Tomography-Based Image Segmentation Predicts Fracture Risk After Spine Stereotactic Body Radiation Therapy.
    Thibault I; Whyne CM; Zhou S; Campbell M; Atenafu EG; Myrehaug S; Soliman H; Lee YK; Ebrahimi H; Yee AJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):75-81. PubMed ID: 27843032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations.
    Guckenberger M; Dahele M; Ong WL; Sahgal A
    Semin Radiat Oncol; 2023 Apr; 33(2):159-171. PubMed ID: 36990633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
    Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases.
    Ozdemir Y; Torun N; Guler OC; Yildirim BA; Besen AA; Yetisken AG; Onal HC; Topkan E
    J Bone Oncol; 2019 Apr; 15():100218. PubMed ID: 30815342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.
    Al-Omair A; Masucci L; Masson-Cote L; Campbell M; Atenafu EG; Parent A; Letourneau D; Yu E; Rampersaud R; Massicotte E; Lewis S; Yee A; Thibault I; Fehlings MG; Sahgal A
    Neuro Oncol; 2013 Oct; 15(10):1413-9. PubMed ID: 24057886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
    Balagamwala EH; Angelov L; Koyfman SA; Suh JH; Reddy CA; Djemil T; Hunter GK; Xia P; Chao ST
    J Neurosurg Spine; 2012 Dec; 17(6):556-64. PubMed ID: 23020208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
    Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M
    Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases.
    Kowalchuk RO; Johnson-Tesch BA; Marion JT; Mullikin TC; Harmsen WS; Rose PS; Siontis BL; Kim DK; Costello BA; Morris JM; Gao RW; Shiraishi S; Lucido JJ; Sio TT; Trifiletti DM; Olivier KR; Owen D; Stish BJ; Waddle MR; Laack NN; Park SS; Brown PD; Merrell KW
    JAMA Oncol; 2022 Mar; 8(3):412-419. PubMed ID: 35084429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.